Company / Capital Expenditures
INTERPACE BIOSCIENCES, INC. Capital Expenditures History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$356.0K
FY2025
5-year range
$176.0K / $876.0K
FY2021-FY2025
Trend
-59.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Capital Expenditures has fluctuated over the past 9 years, ranging from $29,000 in FY2017 to $2M in FY2020.
Based on SEC 10-K filings.
$356,000 in FY2025 with a 5-year CAGR of -25.7%.
Improved from $176,000 to $356,000 over the past 2 years.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- -25.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -25.7%, indicating a declining trend.
- In FY2025, capital expenditures decreased 59.4% year-over-year.
- Peak capital expenditures was recorded in FY2020.
- Lowest capital expenditures in the period was in FY2017.
Company context
Key Data Points
- Altman Z-Score -2.84 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $356.0K | -59.4% |
| FY2024 | $876.0K | +397.7% |
| FY2023 | $176.0K | -45.3% |
| FY2022 | $322.0K | -9.0% |
| FY2021 | $354.0K | -77.5% |
| FY2020 | $1.6M | +1102.3% |
| FY2019 | $131.0K | -70.8% |
| FY2018 | $449.0K | +1448.3% |
| FY2017 | $29.0K | - |
| FY2016 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026